10月2日 - ** Integra LifeSciences（IART.O）股价下跌14.6%，至13.74美元——创5月11日以来新低
** 这家医疗设备制造商将 (link) 2026财年营收预期从此前预估的16.5亿至17.0亿美元下调至16.3亿至16.5亿美元
** 将2026财年调整后每股收益（EPS）预测从2.40–2.50美元下调至2.30–2.40美元
** 将第三季度营收预期从4.10亿至4.25亿美元下调至4.10亿至4.12亿美元
** 称7月辛辛那提工厂遭遇的洪灾导致第三季度营收减少约700万美元；预计对第四季度营收的影响为1500万至2000万美元
** 预计2027年第二季度将全面恢复生产
** 12家券商中有3家给予该股“买入”或更高评级，7家给予“持有”评级，2家给予“卖出”或更低评级；目标价中位数为19美元——LSEG汇编数据
** 计入当日跌幅，该股年初至今累计上涨10.4%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.